Table 3 Relation between serological tests of CMV infection and baseline demographic features among all study participants (n = 201)

Group 1

(Normal pregnancy; n = 128)

Primigravida

0.47 ± 0.19

0.42 ± 0.34

BDL

Multigravida

1.02 ± 0.62

0.57 ± 0.38

126.40 ± 723.63

p-value

0.002

0.09

……

Previous abortion

Yes

1.37 ± 0.56

0.50 ± 0.30

128.53 ± 796.89

no

0.62 ± 0.42

0.60 ± 0.43

117.20 ± 248.64

p-value

< 0.001

0.36

0.101

Preterm labor

Yes

1.48 ± 0.48

0.49 ± 0.23

BDL

no

0.91 ± 0.61

0.56 ± 0.39

148.87 ± 784.49

p-value

0.007

0.98

0.71

Diabetes mellitus

Yes

1.46 ± 0.19

0.71 ± 0.33

746.29 ± 1974.49

no

0.92 ± 0.62

0.54 ± 0.38

32.07 ± 128.09

p value

0.028

0.109

0.729

Group 2

(Pregnant with chronic liver diseases unrelated to pregnancy; n = 35)

Previous abortion

Yes

1.40 ± 0.39

0.51 ± 0.24

BDL

no

1.46 ± 0.77

1.05 ± 0.58

87393.72 ± 219332.71

p -value

1.000

0.013

< 0.001

Group 3

(Pregnant with pregnancy-associated liver disease ;n = 38)

Trimester

First

1.19 ± 0.56

0.56 ± 0.44

BDL

Second

1.52 ± 1.37

0.74 ± 0.54

296.73 ± 372.32

Third

1.31 ± 0.59

0.58 ± 0.37

BDL

p-value

0.854

0.67

0.03

Previous

abortions

Yes

1.91 ± 1.11

0.73 ± 0.44

98.39 ± 290.38

no

0.89 ± 0.49

0.57 ± 0.46

248.83 ± 274.05

p-value

< 0.001

0.15

0.25

Hypertension

Yes

1.70 ± 1.24

0.58 ± 0.38

53.21 ± 199.11

no

1.08 ± 0.54

0.70 ± 0.51

251.90 ± 359.81

p-value

0.04

0.52

0.21